Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT02671539
THOR
Tübingen Choroideremia gene therapy trial open label Phase 2 clinical trial using an
adeno-associated viral vector (AAV2) encoding Rab-escort protein 1 (REP1)
Type: Interventional
Status of the trial: Completed
Orphan Drug Recognition: Yes
Inclusion
- Opening Date: 2016-01-11
- Closing Date: 2016-02-09
Criteria
Children: No
Adults: Yes
Funder Type: other
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
